SEC Form 4 · accession 0000914190-18-000584
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Malcolm C Persen
Director
Period of report
Dec 19, 2018
Accepted (ET)
Dec 21, 2018 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 336,750 | D | ||
| Common Stock | holding | — | — | — | 31,160 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $0.65 | Dec 19, 2018 | A | 46,457 | A | — | Dec 19, 2028 | Common Stock | 46,457 | 46,457 | D |
| Warrants (right to buy) | $0.85 | holding | — | — | — | May 12, 2015 | May 18, 2020 | Common Stock | 15,580 | 15,580 | I |
| Stock Option (Right to Buy)F2 | $0.79 | holding | — | — | — | — | May 7, 2025 | Common Stock | 56,981 | 56,981 | D |
| Stock Option (Right to Buy)F2 | $0.40 | holding | — | — | — | — | Aug 24, 2026 | Common Stock | 33,880 | 33,880 | D |
| Stock Option (Right to Buy)F3 | $0.4999 | holding | — | — | — | — | Dec 20, 2027 | Common Stock | 40,284 | 40,284 | D |
Explanation of responses
- F1Includes 71,509 shares of restricted stock that vest on 6/14/19.
- F2Fully exercisable.
- F3The option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.
- F4On December 19, 2018, the Company granted an option to purchase 46,457 shares of common stock of the Company (the "Option") in respect of the service by Mr. Persen as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 15,486 shares on each of 12/19/18 and 12/19/19, and as to 15,485 shares on 12/19/20.